We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
AdvaMed and Deloitte have updated their 2017 report on assessing the value of diagnostic technologies by incorporating a look at how the shift of risk from payer to provider will affect the adoption of new medtech innovations — while at the same time, reducing cost, improving patient experience, outcomes and satisfaction. Read More
Helping consumers avoid adverse events from improper use of hydrogen peroxide-based contact lens care products (HPCP) by improving labeling is the aim of a final guidance the FDA released Wednesday. Read More
Drug-device combination products can pose cumbersome regulatory challenges for companies, say regulatory experts, primarily because the product has to comply with two complicated regulatory systems that are not designed to work together. Read More
Recalls can be messy, complicated matters, especially for manufacturers that don’t have a plan in place for analyzing a problem, determining a course of action and carrying out all recall-related tasks in compliance with FDA requirements. Read More
CDRH has recognized low temperature vaporized hydrogen peroxide as an alternative to ethylene oxide (EtO) for medical device sterilization and is updating its reference documentation to assist manufacturers in making changes to sterilization procedures. Read More
The FTC and HHS have teamed up on a campaign about the privacy and security risks associated with online tracking technologies integrated into mobile health apps and websites with a letter to 130 hospital systems and telehealth providers. Read More
The Senate Health, Education, Labor and Pensions (HELP) Committee has advanced reauthorization of the 2006 Pandemic and All Hazards Preparedness Act (PAHPA), allowing the FDA to require that manufacturers notify the agency of potential product shortages when there’s no public health emergency (PHE). Read More
A regulatory affairs specialist for an eastern Pennsylvania medical device company has pled guilty to fabricating documents on FDA letterhead representing that two of his company’s products had received 510(k) clearances when, in fact, he had never made any submissions for the devices. Read More